| 000 | 01865 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517004223.0 | ||
| 264 | 0 | _c20150217 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1096-0333 | ||
| 024 | 7 |
_a10.1016/j.taap.2014.10.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEldridge, Sandy R | |
| 245 | 0 | 0 |
_aCharacterization of acute biliary hyperplasia in Fisher 344 rats administered the indole-3-carbinol analog, NSC-743380. _h[electronic resource] |
| 260 |
_bToxicology and applied pharmacology _cDec 2014 |
||
| 300 |
_a303-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBiliary Tract _xdrug effects |
| 650 | 0 | 4 |
_aBiliary Tract Diseases _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aDrugs, Investigational _xadministration & dosage |
| 650 | 0 | 4 | _aHyperplasia |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aCovey, Joseph | |
| 700 | 1 | _aMorris, Joel | |
| 700 | 1 | _aFang, Bingliang | |
| 700 | 1 | _aHorn, Thomas L | |
| 700 | 1 | _aElsass, Karen E | |
| 700 | 1 | _aHamre, John R | |
| 700 | 1 | _aMcCormick, David L | |
| 700 | 1 | _aDavis, Myrtle A | |
| 773 | 0 |
_tToxicology and applied pharmacology _gvol. 281 _gno. 3 _gp. 303-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2014.10.015 _zAvailable from publisher's website |
| 999 |
_c24402623 _d24402623 |
||